Myrexis is a biopharmaceutical company based in Salt Lake City, Utah, USA. It focuses on drug development in several areas of medicine, in particular cancer therapy. It was founded in 1999 as a spin-off from Myriad Genetics and was originally known as Myriad Pharmaceuticals. Richard B. Brewer was its CEO from May 2012 until his death in August 2012.